logo IDIBELL
Català  |   Castellano  |   English
Search
The InstituteResearchWhat's onPlatformsJoin usTools
 

Infections and Cancer




Research lines

Human papilloma virus (HPV) and genital cancer.

HPV and esophagus, oral cavity, skin, vagina, vulva, penis and anus cancer.

Hepatotropic virus (Hepatitis B and C viruses– HBV and HCV) and liver cancer.

VPH vaccination trials and intervention studies on cancer prevention.

Infectious etiology of malignant lymphomas.

WHO/ICO Information Center on HPV & Cervical Cancer.

Development of logistical tools for the coordination and the information broadcasting about virus and cancer.

Screening and prevention of genital cancer.

Evaluation of viral detection technologies.

Modelling and economic evaluation of cancer prevention measures


Papers 2014


Spanish journals
 
UNIC

Falo C, Villar H, Rodriguez E, Mena M, Font A. Calidad de vida en cáncer de mama metastásico de larga evolución: la opinión de las pacientesPsicooncología 2014; 11: 313-31
 
International Journals
UNIC
 
 
Acera A, Manresa JM, Rodríguez D, Rodríguez A, Bonet JM, Sánchez N, Hidalgo P, Soteras P, Toran P, Trapero-Bertran M, Lozano I, de Sanjosé SAnalysis of three strategies to increase screening coverage for cervical cancer in the general population of women aged 60 to 70 years: the CRICERVA study. BMC Womens Health. 2014 Jul 16;14(1):86. IF: 1,657; Q3; PMID: 25026889
 
Ahrens W, Pohlabeln H, Foraita R, Nelis M, Lagiou P, Lagiou A, Bouchardy C, Slamova A, Schejbalova M, Merletti F, Richiardi L, Kjaerheim K, Agudo ACastellsagué X, Macfarlane TV, Macfarlane GJ, Lee YC, Talamini R, Barzan L, Canova C, Simonato L, Thomson P, McKinney PA, McMahon AD, Znaor A, Healy CM, McCartan BE, Metspalu A, Marron M, Hashibe M, Conway DI, Brennan P. Oral health, dental care and mouthwash associated with upper aerodigestive tract cancer risk in Europe: the ARCAGE study. Oral Oncol. 2014 Jun;50(6):616-25. doi: 10.1016/j.oraloncology.2014.03.001. Epub 2014 Mar 27.IF: 3,029. Q2 (Oncology); PMID: 24680035
 
Albero G, Castellsagué X, Lin HY, Fulp W, Villa LL, Lazcano-Ponce E, Papenfuss M, Abrahamsen M, Salmerón J, Quiterio M, Nyitray AG, Lu B, Bosch FX, Giuliano AR. Male circumcision and the incidence and clearance of genital human papillomavirus (HPV) infection in men: the HPV Infection in men (HIM) cohort study. BMC Infect Dis. 2014 Feb 10;14(1):75. IF: 2,561; Q2; PMID: 24517172
 
Alemany Lde Sanjosé STous S, Quint W, Vallejos C, Shin Hai-Rim, Bravo LE, Alonso P, Marcus AL, Guimerà N, Klaustermeier JE, Llombart-Bosch A, Kasamatsu E, Tatti SA, Felix A, Molina C, Velasco J, Lloveras B, Clavero O, Lerma E, Laco J, Bravo IG, Guarch R, Pelayo A, Ordi J, Andújar M, Sanchez GI, Castellsagué X, Muñoz N, Bosch FX*; on behalf of the RIS HPV TT study group. Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007. Int J Cancer 2014 Jul 1;135(1):88-95. IF: 5,007; Q1; PMID: 24382655
 
Alemany L, Saunier M, Alvarado-Cabrero I, Quirós B, Salmeron J, Shin HR, Pirog EC, Guimerà N, Hernandez-Suarez G, Felix A, Clavero O, Lloveras B, Kasamatsu E, Goodman MT, Hernandez BY, Laco J, Tinoco L, Geraets DT, Lynch CF, Mandys V, Poljak M, Jach R, Verge J, Clavel C, Ndiaye C, Klaustermeier J, Cubilla A, Castellsagué XBravo IG, Pawlita M, Quint WG, Muñoz N, Bosch FXde Sanjosé S; on behalf of the HPV VVAP study group. HPV DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer. 2015 Jan 1;136(1):98-107. doi: 10.1002/ijc.28963. Epub 2014 May 30. IF: 5,007; Q1; PMID: 24817381
 
Castellsagué X, Pawlita M, Roura E, Margall N, Waterboer T, Bosch FXde Sanjosé SGonzalez CA, Dillner J, Gram IT, Tjønneland A, Munk C, Pala V, Palli D, Khaw KT, Barnabas RV, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Fagherazzi G, Kaaks R, Lukanova A, Steffen A, Trichopoulou A, Trichopoulos D, Klinaki E, Tumino R, Sacerdote C, Mattiello A, Bueno-de-Mesquita HB, Peeters PH, Lund E, Weiderpass E, Quirós JR, Sánchez MJ, Navarro C, Barricarte A, Larrañaga N, Ekström J, Hortlund M, Lindquist D, Wareham N, Travis RC, Rinaldi S, Tommasino M, Franceschi S, Riboli E. Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: Evidence from the EPIC cohort. Int J Cancer. 2014 Jan 6;135: 440–452. IF: 5,007; Q1; PMID: 24338606
 
Castellsagué X, Naud P, Chow SN, Wheeler CM, Germar MJ, Lehtinen M, Paavonen J, Jaisamrarn U, Garland SM, Salmerón J, Apter D, Kitchener H, Teixeira JC, Skinner SR, Limson G, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, de Carvalho NS, Peters K, Tjalma WA, Safaeian M, Raillard A, Descamps D, Struyf F, Dubin G, Rosillon D, Baril L. Risk of newly detected infections and cervical abnormalities in women seropositive for naturally-acquired HPV-16/18 antibodies: analysis of the control arm of PATRICIAJ Infect Dis. 2014 Aug 15;210(4):517-34. doi: 10.1093/infdis/jiu139. Epub 2014 Mar 8. IF: 5,778; Q1; PMID: 24610876
 
Chen AA, Heideman DA, Boon D, Gheit T, Snijders PJ, Tommasino M, Franceschi S, Clifford GM; IARC HPV Variant Study GroupHuman papillomavirus 45 genetic variation and cervical cancer risk worldwideJ Virol. 2014 Apr;88(8):4514-21. IF: 4,648; Q1; PMID: 24501412
 
Cozen W, Timofeeva MN, Li D, Diepstra A, Hazelett D, Delahaye-Sourdeix M, Edlund CK, Franke L, Rostgaard K, Van Den Berg DJ, Cortessis VK, Smedby KE, Glaser SL, Westra HJ, Robison LL, Mack TM, Ghesquieres H, Hwang AE, Nieters A, de Sanjosé S, Lightfoot T, Becker N, Maynadie M, Foretova L, Roman E, Benavente Y, Rand KA, Nathwani BN, Glimelius B, Staines A, Boffetta P, Link BK, Kiemeney L, Ansell SM, Bhatia S, Strong
LC, Galan P, Vatten L, Habermann TM, Duell EJ, Lake A, Veenstra RN, Visser L, Liu Y, Urayama KY, Montgomery D, Gaborieau V, Weiss LM, Byrnes G, Lathrop M, Cocco P, Best T, Skol AD, Adami HO, Melbye M, Cerhan JR, Gallagher A, Taylor GM, Slager SL, Brennan P, Coetzee GA, Conti DV, Onel K, Jarrett RF, Hjalgrim H, van den Berg A, McKay JD. A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus. Nat Commun. 2014 Jun 12;5:3856. IF: 10.742; Q1; PMID: 24920014
 
García-Pérez R, Ibáñez C, Godínez JM, Aréchiga N, Garin I, Pérez-Suárez G, de Paz O, Juste J, Echevarría JE, Bravo IGNovel papillomaviruses in free-ranging Iberian bats: no virus-host co-evolution, no strict host specificity, and hints for recombination. Genome Biol Evol. 2014 Jan;6(1):94-104. IF: 4,532; Q1; PMID: 24391150
 
Gillison ML, Castellsagué X, Chaturvedi A, Goodman MT, Snijders P, Tommasino M, Arbyn M, Franceschi S. Eurogin Roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervixInt J Cancer. 2014 Feb 1;134(3):497-507. IF: 5,007; Q1; PMID: 23568556
 
Godínez JMNicolás-Párraga SPimenoff VNMengual-Chuliá B, Muñoz N, Bosch FX, Sánchez GI, McCloskey J, Bravo IGPhylogenetically related, clinically different: human papillomaviruses 6 and 11 variants distribution in genital warts and in laryngeal papillomatosisClin Microbiol Infect. 2014 Jun;20(6):O406-13. IF: 5,197; Q1; PMID: 24118667
 
Houlihan CF, de Sanjosé S, Baisley K, Changalucha J, Ross DA, Kapiga S, Godínez JM, Bozicevic I, Hayes RJ, Watson-Jones D. Prevalence of Human Papillomavirus in Adolescent Girls Before Reported Sexual Debut. J Infect Dis. 2014 Sep 15;210(6):837-45. doi: 10.1093/infdis/jiu202. Epub 2014 Apr 16. IF: 5,778; Q1; PMID: 24740630
 
Ibáñez R, Félez-Sánchez M, Godínez JM, Guardià C, Caballero E, Juve R, Combalia N, Bellosillo B, Cuevas D, Moreno-Crespi J, Pons L, Autonell J, Gutierrez C, Ordi J, de Sanjosé S, Bravo IGInterlaboratory reproducibility and proficiency testing within the human papillomavirus cervical cancer screening program in Catalonia, SpainJ Clin Microbiol.52(5):1511-8. doi: 10.1128/JCM.00100-14. Epub 2014 Feb 26. IF: 4,232; Q1; PMID: 24574284
 
Iljazović E, Mena MTous SAlemany L, Omeragić F, Sadiković A, Clavero O, Vergara M, Bosch FXde Sanjosé SHuman Papillomavirus genotype distribution in invasive cervical cancer in Bosnia and Herzegovina. Cancer Epidemiol. 2014 Oct;38(5):504-10. doi: 10.1016/j.canep.2014.06.004. Epub 2014 Aug 11. IF: 2,558; Q3 (Oncology); PMID: 25130915
 
Leoncini E, Ricciardi W, Cadoni G, Arzani D, Petrelli L, Paludetti G, Brennan P, Luce D, Stucker I, Matsuo K, Talamini R, La Vecchia C, Olshan AF, Winn DM, Herrero R, Franceschi S, Castellsagué X, Muscat J, Morgenstern H, Zhang ZF, Levi F, Dal Maso L, Kelsey K, McClean M, Vaughan TL, Lazarus P, Purdue MP, Hayes RB, Chen C, Schwartz SM, Shangina O, Koifman S, Ahrens W, Matos E, Lagiou P, Lissowska J, Szeszenia-Dabrowska N, Fernandez L, Menezes A, Agudo A, Daudt AW, Richiardi L, Kjaerheim K, Mates D, Betka J, Yu GP, Schantz S, Simonato L, Brenner H, Conway DI, Macfarlane TV, Thomson P, Fabianova E, Znaor A, Rudnai P, Healy C, Boffetta P, Chuang SC, Lee YC, Hashibe M, Boccia S. Adult height and head and neck cancer: a pooled analysis within the INHANCE ConsortiumEur J Epidemiol. 2014 Jan;29(1):35-48. IF: 5,147; Q1; PMID: 24271556
 
Lubin JH, De Stefani E, Abnet CC, Acosta G, Boffetta P, Victora C, Graubard BI, Muñoz N, Deneo-Pellegrini H, Franceschi S, Castellsagué X, Ronco AL, Dawsey SM. Maté drinking and esophageal squamous cell carcinoma in South America: pooled results from two large multicenter case-control studiesCancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):107-16. IF: 4,324; Q1; PMID: 24130226
 
Mengual-Chuliá , B., Domenis, L., Robetto, S., Bravo, IGA novel papillomavirus isolated from a nasal neoplasia in an Italian free-ranging chamois (Rupicapra r. rupicapra)Vet Microbiol. 2014 Aug 6;172(1-2):108-19. IF: 2,726; Q2 (Microbiology); PMID: 24910075
 
Pelchovich G, Sigal N, Dana A, Tuller T, Bravo IG, Gophna U. Ribosomal mutations affecting the translation of genes that use non-optimal codonsFEBS J. 2014 Aug;281(16):3701-18. doi: 10.1111/febs.12892. Epub 2014 Aug 8. IF: 3,986; Q2; PMID: 24966114
 
Pirog EC, Lloveras B, Molijn A, Tous S, Guimerà N, Alejo M, Clavero OKlaustermeier J, Jenkins D, Quint W, Bosch FXAlemany Lde Sanjosé S; on behalf of the RIS HPV TT study group. HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 casesMod Pathol. 2014 Dec;27(12):1559-67. doi: 10.1038/modpathol.2014.55. Epub 2014 Apr 25. IF: 6,364; Q1; PMID: 24762548
 
Pérez C, Castillo M, Alemany LTous S, Klaustermeier J, de Sanjose S, Velasco J. Evaluation of p16INK4a Overexpression in a Large Series of Cervical Carcinomas: Concordance With SPF10-LiPA25 PCRInt J Gynecol Pathol. 2014;33(1):74-82. IF: 1,631; Q3; PMID: 24300539
 
Teras LR, Rollison DE, Pawlita M, Michel A, Brozy J, de Sanjosé S, Blase JL, Gapstur SM. Epstein-Barr virus and risk of non-Hodgkin lymphoma in the cancer prevention study-II and a meta-analysis of serologic studiesInt J Cancer. 2015 Jan 1;136(1):108-16. doi: 10.1002/ijc.28971. Epub 2014 Jun 5. IF: 5,007; Q1; PMID: 24831943
 
Van Kriekinge G, Castellsagué X, Cibula D, Demarteau N. Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths.Vaccine. 2014 Feb 3;32(6):733-9. IF: 3,485; Q2; PMID: 24291200
 
Alemany LSaunier M, Tinoco L, Quirós B, Alvarado-Cabrero I, Alejo M, Joura EA, Maldonado P, Klaustermeier J, Salmerón J, Bergeron C, Petry KU, Guimerà N, Clavero O, Murillo R, Clavel C, Wain V, Geraets DT, Jach R, Cross P, Carrilho C, Molina C, Shin HR, Mandys V, Nowakowski AM, Vidal A, Lombardi L, Kitchener H, Sica AR, Magaña-León C, Pawlita M, Quint W, Bravo IG, Muñoz N, de Sanjosé SBosch FX; HPV VVAP study group. Large contribution of human papillomavirus in vaginal neoplastic lesions: A worldwide study in 597 samplesEur J Cancer. 2014 Nov;50(16):2846-54. doi: 10.1016/j.ejca.2014.07.018. Epub 2014 Aug 21. IF: 4,819; Q1; PMID: 25155250
 
Halec G, Alemany L, Lloveras B, Schmitt M, Alejo M, Bosch FX, Tous SKlaustermeier JE, Guimerà N, Grabe N, Lahrmann B, Gissmann L, Quint W, Bosch FXde Sanjose S, Pawlita M. Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancerJ Pathol. 2014 Dec;234(4):441-51. doi: 10.1002/path.4405. Epub 2014 Sep 12. IF: 7,330; Q1; PMID: 25043390
 
Ibáñez R, Autonell J, Sardà M, Crespo N, Pique P, Pascual A, Martí C, Fibla M, Gutiérrez C, Lloveras B, Moreno-Crespi J, Torrent A, Baixeras N, Alejo M, Bosch FX, de Sanjosé S.Protecting the underscreened women in developed countries: the value of HPV testBMC Cancer. 2014 Aug 8;14:574. doi: 10.1186/1471-2407-14-574. IF: 3.319; Q2; PMID: 25102758
 
Cathy Ndiaye PhD, Dr Marisa Mena PhD, Laia Alemany MD, Marc Arbyn DrTMH, Xavier Castellsagué PhD, Louise Laporte BS, F Xavier Bosch MD , Silvia de Sanjosé PhD, Helen Trottier PhD. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysisThe Lancet Oncology, Volume 15, Issue 12, Pages 1319 - 1331, November 2014. IF: 24,725; Q1; PMID: 25439690
 
Serrano B, Alemany L, Ruiz PA, Tous S, Lima MA, Bruni L, Jain A, Clifford GM, Qiao YL, Weiss T, Bosch FXde Sanjosé SPotential impact of a 9-valent HPV vaccine in HPV-related cervical disease in 4 emerging countries (Brazil, Mexico, India and China)Cancer Epidemiol. 2014 Dec;38(6):748-56. doi: 10.1016/j.canep.2014.09.003. Epub 2014 Oct 8. IF: 2,558; Q3 (Oncology); PMID: 25305098
 
Joura EA, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris D, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Miller D, Monsonego J, Munoz N, Myers E, Paavonen J, Pitisuttithum P, Steben M, Wheeler CM, Perez G, Saah A, Luxembourg A, Sings HL, Velicer C. Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical diseaseCancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):1997-2008. doi: 10.1158/1055-9965.EPI-14-0410. IF: 4,324; Q1; PMID: 25274978
 
Castellsagué X, Jorma Paavonen, Unnop Jaisamrarn, Cosette M Wheeler, S Rachel Skinner, Matti Lehtinen, Paulo Naud, Song-Nan Chow, Maria Rowena Del Rosario-Raymundo, Julio C Teixeira, Johanna Palmroth, Newton S de Carvalho, Maria Julieta V Germar, Klaus Peters, Suzanne M Garland, Anne Szarewski, Willy AJ Poppe, Barbara Romanowski, Tino F Schwarz, Wiebren AA Tjalma, Bosch FX, Marie-Cecile Bozonnat, Frank Struyf, Gary Dubin, Dominique Rosillon, Laurence Baril and for the HPV PATRICIA Study Group. Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trialBMC Infectious Diseases 2014, 14:551  doi:10.1186/s12879-014-0551-y. IF: 2.561. Q2
 
Rodríguez-Salés V, Ortiz-Barreda G, de Sanjosé S. Scoping review on cancer prevention in immigrants living in Spain.  Rev Esp Salud Publica. 2014 Nov-Dec;88(6):735-43. doi: 10.4321/S1135-57272014000600006. Spanish. IF: --. PMID: 25418564
 
Sanjosé S de, Robles C, Waterboer T, Casabonne D, Michel A, Benavente Y, Costas L, Gonzalez-Barca E, Aymerich M, Campo E, Tardon A, Garcia Sanmartin P, Castaño-Vinyals G, Dierssen-Sotos T, Aragones N, Pollan M, Kogevinas M, Pawlita M. Abnormal Seroresponse to Common Viruses in CLL RAI0Blood. 2014 Dec 6;124(21):5632. IF: 9,775, Q1 Hematology
 
Skibola CF, Berndt SI, Vijai J, Conde L, Wang Z, Yeager M, de Bakker PI, Birmann BM, Vajdic CM, Foo JN, Bracci PM, Vermeulen RC, Slager SL, de Sanjose S, Wang SS, Linet MS, Salles G, Lan Q, Severi G, Hjalgrim H, Lightfoot T, Melbye M, Gu J, Ghesquières H, Link BK, Morton LM, Holly EA, Smith A, Tinker LF, Teras LR, Kricker A, Becker N, Purdue MP, Spinelli JJ, Zhang Y, Giles GG, Vineis P,Monnereau A, Bertrand KA, Albanes D, Zeleniuch-Jacquotte A, Gabbas A, Chung CC, Burdett L, Hutchinson A, Lawrence C, Montalvan R, Liang L, Huang J, Ma B, Liu J, Adami HO, Glimelius B, Ye Y, Nowakowski GS, Dogan A, Thompson CA, Habermann TM,Novak AJ, Liebow M, Witzig TE, Weiner GJ, Schenk M, Hartge P, De Roos AJ, Cozen W, Zhi D, Akers NK, Riby J, Smith MT, Lacher M, Villano DJ, Maria A, Roman E, Kane E, Jackson RD, North KE, Diver WR, Turner J, Armstrong BK,Benavente Y, Boffetta P, Brennan P, Foretova L, Maynadie M, Staines A, McKay J, Brooks-Wilson  AR, Zheng T, Holford TR, Chamosa S, Kaaks R, Kelly RS, Ohlsson B, Travis RC, Weiderpass E, Clavel J, Giovannucci E, Kraft P, Virtamo J, Mazza P, Cocco P, Ennas MG, Chiu BC, Fraumeni JF Jr, Nieters A, Offit K, Wu X, Cerhan JR, Smedby KE, Chanock SJ, Rothman N. Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA regionAm J Hum Genet. 2014 Oct 2;95(4):462-71. doi: 10.1016/j.ajhg.2014.09.004. IF: 10,987; Q1; PMID: 25279986
 
Cerhan JR, Berndt SI, Vijai J, Ghesquières H, McKay J, Wang SS, Wang Z, Yeager M, Conde L, de Bakker PI, Nieters A, Cox D, Burdett L, Monnereau A, Flowers CR, De Roos AJ, Brooks-Wilson AR, Lan Q, Severi G, Melbye M, Gu J, Jackson RD, Kane E, Teras LR, Purdue MP, Vajdic CM, Spinelli JJ, Giles GG, Albanes D, Kelly RS, Zucca M, Bertrand KA, Zeleniuch-Jacquotte A, Lawrence C, Hutchinson A, Zhi D, Habermann TM, Link BK, Novak AJ, Dogan A, Asmann YW, Liebow M, Thompson CA, Ansell SM, Witzig TE, Weiner GJ, Veron AS, Zelenika D, Tilly H, Haioun C, Molina TJ, Hjalgrim H, Glimelius B, Adami HO, Bracci PM, Riby J, Smith MT, Holly EA, Cozen W, Hartge P, Morton LM, Severson RK, Tinker LF, North KE, Becker N, Benavente Y, Boffetta P, Brennan P, Foretova L, Maynadie M, Staines A, Lightfoot T, Crouch S, Smith A, Roman E, Diver WR, Offit K, Zelenetz A, Klein RJ, Villano DJ, Zheng T, Zhang Y, Holford TR, Kricker A, Turner J, Southey MC, Clavel J, Virtamo J, Weinstein S, Riboli E, Vineis P, Kaaks R, Trichopoulos D, Vermeulen RC, Boeing H, Tjonneland A, Angelucci E, Di Lollo S, Rais M, Birmann BM, Laden F, Giovannucci E, Kraft P, Huang J, Ma B, Ye Y, Chiu BC, Sampson J, Liang L, Park JH, Chung CC, Weisenburger DD, Chatterjee N, Fraumeni JF Jr, Slager SL, Wu X, de
Sanjosé S, Smedby KE, Salles G, Skibola CF, Rothman N, Chanock SJ. Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphomaNat Genet. 2014 Nov;46(11):1233-8. doi: 10.1038/ng.3105. Epub 2014 Sep 28. IF: 29,648; Q1; PMID: 25261932
 
Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF, Bracci PM, de Sanjosé S, Smedby KE, Chiu BC, Zhang Y, Mbulaiteye SM, Monnereau A, Turner JJ, Clavel J, Adami HO, Chang ET, Glimelius B, Hjalgrim H, Melbye M, Crosignani P, di Lollo S, Miligi L, Nanni O, Ramazzotti V, Rodella S, Costantini AS, Stagnaro E, Tumino R, Vindigni C, Vineis P, Becker N, Benavente Y, Boffetta P, Brennan P, Cocco P, Foretova L, Maynadié M, Nieters A, Staines A, Colt JS, Cozen W, Davis S, de Roos AJ, Hartge P, Rothman N, Severson RK, Holly EA, Call TG, Feldman AL, Habermann TM, Liebow M, Blair A, Cantor KP, Kane EV, Lightfoot T, Roman E, Smith A, Brooks-Wilson A, Connors JM, Gascoyne RD, Spinelli JJ, Armstrong BK, Kricker A, Holford TR, Lan Q, Zheng T, Orsi L, Dal Maso L, Franceschi S, La Vecchia C, Negri E, Serraino D, Bernstein L, Levine A, Friedberg JW, Kelly JL, Berndt SI, Birmann BM, Clarke CA, Flowers CR, Foran JM, Kadin ME, Paltiel O, Weisenburger DD, Linet MS, Sampson JN. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectJ Natl Cancer Inst Monogr. 2014 Aug;2014(48):130-44. doi: 10.1093/jncimonographs/lgu013. PMID: 25174034. IF: 15,161. Q1
 
Bracci PM, Benavente Y, Turner JJ, Paltiel O, Slager SL, Vajdic CM, Norman AD, Cerhan JR, Chiu BC, Becker N, Cocco P, Dogan A, Nieters A, Holly EA, Kane EV, Smedby KE, Maynadié M, Spinelli JJ, Roman E, Glimelius B, Wang SS, Sampson JN, Morton LM, de Sanjosé SMedical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectJ Natl Cancer Inst Monogr. 2014 Aug;2014(48):52-65. doi: 10.1093/jncimonographs/lgu011. PMID: 25174026. IF: 15,161. Q1
 
Slager SL, Benavente Y, Blair A, Vermeulen R, Cerhan JR, Costantini AS, Monnereau A, Nieters A, Clavel J, Call TG, Maynadié M, Lan Q, Clarke CA, Lightfoot T, Norman AD, Sampson JN, Casabonne D, Cocco P, de Sanjosé SMedical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectJ Natl Cancer Inst Monogr. 2014 Aug;2014(48):41-51. doi: 10.1093/jncimonographs/lgu001. PMID: 25174025. IF: 15,161. Q1
 
Linet MS, Vajdic CM, Morton LM, de Roos AJ, Skibola CF, Boffetta P, Cerhan JR, Flowers CR, de Sanjosé S, Monnereau A, Cocco P, Kelly JL, Smith AG, Weisenburger DD, Clarke CA, Blair A, Bernstein L, Zheng T, Miligi L, Clavel J, Benavente Y, Chiu BC. Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectJ Natl Cancer Inst Monogr. 2014 Aug;2014(48):26-40. doi: 10.1093/jncimonographs/lgu006. PMID: 25174024. IF: 15,161. Q1
 
Mbulaiteye SMMorton LMSampson JNChang ETCostas Lde Sanjosé SLightfoot TKelly JFriedberg JWCozen WMarcos-Gragera RSlager SLBirmann BM,Weisenburger DD. Medical history, lifestyle, family history, and occupational risk factors for sporadic Burkitt lymphoma/leukemia: the Interlymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014 Aug;2014(48):106-14. doi: 10.1093/jncimonographs/lgu003. PMID: 25174031. IF: 15,161. Q1
 
Morton LM, Sampson JN, Cerhan JR, Turner JJ, Vajdic CM, Wang SS, Smedby KE, de Sanjosé S, Monnereau A, Benavente Y, Bracci PM, Chiu BC, Skibola CF, Zhang Y, Mbulaiteye SM, Spriggs M, Robinson D, Norman AD, Kane EV, Spinelli JJ, Kelly JL, La Vecchia C, Dal Maso L, Maynadié M, Kadin ME, Cocco P, Costantini AS, Clarke CA, Roman E, Miligi L, Colt JS, Berndt SI, Mannetje A, de Roos AJ, Kricker A, Nieters A, Franceschi S, Melbye M, Boffetta P, Clavel J, Linet MS, Weisenburger DD, Slager SL. Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014 Aug;2014(48):1-14. doi: 10.1093/jncimonographs/lgu005. PMID:  25174022. IF: 15,161. Q1
 
de Sanjosé S, Bruni L, Alemany L. HPV in genital cancers (at the exception of cervical cancer) and anal cancers. Presse Med. 2014 Oct 30;43(12P2):e423-e428. doi: 10.1016/j.lpm.2014.10.001. [Epub ahead of print]. IF: 1,173; Q3; PMID : 25455637
 
Costas L, de Sanjosé S, Infante-Rivard C. Reproductive factors and non-Hodgkin lymphoma: A systematic reviewCrit Rev Oncol Hematol. 2014 Dec;92(3):181-193. IF: 4,046; Q2; PMID: 25132165
 
Roura E, Castellsagué X, Pawlita M, Travier N, Waterboer T, Margall N, Bosch FX, de Sanjosé S, Dillner J, Gram IT, Tjønneland A, Munk C, Pala V, Palli D, Khaw KT, Barnabas RV, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Fagherazzi G, Kaaks R, Lukanova A, Steffen A, Trichopoulou A, Trichopoulos D, Klinaki E, Tumino R, Sacerdote C, Panico S, Bueno-de-Mesquita HB, Peeters PH, Lund E, Weiderpass E, Redondo ML, Sánchez MJ, Tormo MJ, Barricarte A, Larrañaga N, Ekström J, Hortlund M, Lindquist D, Wareham N, Travis RC, Rinaldi S, Tommasino M, Franceschi S, Riboli E. Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort. Int J Cancer. 2014 Jul 15;135(2):453-66. IF: 5,007; Q1; PMID: 24338632
 
Andreotti GBirmann BMCozen WDe Roos AJChiu BCCostas Lde Sanjosé SMoysich KCamp NJSpinelli JJPahwa PDosman JAMcLaughlin JRBoffetta PStaines A,Weisenburger DBenhaim-Luzon VBrennan PCostantini ASMiligi LCampagna MNieters ABecker NMaynadié MForetová LZheng TTricot GMilliken KKrzystan J,Steplowski EBaris DPurdue MPA Pooled Analysis of Cigarette Smoking and Risk of Multiple Myeloma from the International Multiple Myeloma ConsortiumCancer Epidemiol Biomarkers Prev. 2014 Dec 23. [Epub ahead of print]. IF: 4,3. Q1. D1. PMID: 25538226

European Commission

 

Funding:  European Commission. 7th Framework Programme

Project: Comparing Health Services interventions for the prevention of HPV-related cancer (CoheaHr)

Principal Investigator: Bosch FX (Spain) (Coordinator: CJLM Meijer)

Co-researchers: Castellsagué X, de Sanjosé S, Bruni L, Sedano A, Ibañez R, Roura R

Ref.: HEALTH 2013.3.1-1.

Amount Granted: 675.000,12€

Duration: 2013-2018

 

Funding: European Commission. 7th Framework Programme

Project: HPV-AHEAD-Role of human papillomavirus infection and other co-factors in the aetiology of head and neck cancer in Europe and India

Principal Investigator: Bosch FX

Co-researchers: de Sanjosé S, Castellsagué X, Alemany L

Ref.: 282562

Amount Granted: 200.958€

Duration: 2011-2013

 

Funding: European Commission

Project: Supporting innovative learning approaches through Mobile Integration in the workpLacE - Oncology Nursing SMILEON

Principal Investigator: Sedano A

Co-researchers: Company A, Fernández P, Montserrat M

Ref.: 518383-LLP-2011- Leonardo-ES-LMP

Amount Granted: 398.346 € (Importe grupo : 172.253€ ICO)

Duration: 2011-2013

 

Funding: European Commission. 7th Framework Programme

Project: Health-economic modelling of PREvention strategies for HPV-related Diseases in European CounTries. PREHDICT

Principal Investigator: Bosch FX

Co-researchers: Castellsagué X, de Sanjosé S, Diaz M, Muñoz J, Bruni L, Brotons M

Ref.: 242061

Amount Granted: Importe grupo: 398.702€

Duration: 2009-2013

 

 

Spain Government

 

Funding: Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III)

Project: Estudio internacional sobre la distribución de genotipos específicos del Virus del Papiloma Humano (VPH) en los cánceres de faringe y laringe

Principal Investigator: Castellsagué X

Co-researchers: Alemany L, Albero G, Guimerà N, Klaustermeier JE, Lloveras B, Alejo M, Clavero O

Ref.: PI081535

Amount Granted: 183.920€

 

Funding: Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III)

Project: Modelo dinámico de transmisión de la infección por los VPHs 16 y 18. Implicaciones económicas y sanitarias en la población española según diferentes escenarios de vacunación.

Principal Investigator: Díaz M

Co-researchers: Kim JJ, Ibáñez R

Ref. PI11/02090

Amount Granted: 67.429,67€

Duration: 2011-2013

 

Funding: Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III)

Project: Detección de ADN del Virus del Papiloma Humano (VPH) en cánceres anogenitales en España. Estudio complementario a PREHDICT, proyecto europeo del VII Programa Marco.

Principal Investigator: Bosch FX

Ref.: PI10/02995

Amount Granted: 114.224€

Duration: 2011-2013

 

Funding: Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III)

Project: Ampliando el espectro de papilomavirus (VP) relacionados con el cáncer humano: detección y actividad biológica de VPH cutáneos y VP no humanos en los cánceres de cabeza y cuello

Principal Investigator: Castellsagué X

Co-researchers: Godínez J, Quiros B, Alemany L, Klaustermeier J y Alejo M

Ref.: PI11/02104

Amount Granted: 156.128€

Duration: 2011-2014

 

Funding: Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III)

Project: El papel etiológico y pronóstico del Virus del Papiloma en pacientes con cáncer de orofaringe

Principal Investigator: Bosch FX

Co-researchers: Alemany L, Lloveras B, Esteban A, Maños A, Marí A, Bonfill T, Aguila A, García J, Gras JR

Ref.: PI11/02096

Amount Granted: 413.820€

Duration: 2011-2015

 

Funding: Fondo de Investigación Sanitaria (Instituto de Salud Carlos III)

Project: Factores de riesgo ambientales, infecciosos y genéticos asociados a la leucemia linfática crónica (LLC), en el marco del estudio Multi-Caso-Control (MCC-SPAIN)

Principal Investigator: de Sanjosé S

Co-researchers: Dierssen T, Costas L, Garcia M, Castaño G, Benavente Y, Gomez I,  Gonzalez Barca E, Robles C, Alonso ME, Casabonne D, Rios R, Vergara M, de Oliveira AC

Ref.: PI11/01810

Amount Granted: 262.130,55€

Duration: 2011–2014

 

Funding: Ministerio de Ciencia e Innovación. Centro Superior de Investigación en Salud Pública. MICINN.

Project: Biodiversidad y evolución de papillomaviruses.

Principal Investigator: Bravo IG

Ref.: CGL2010-16713 (subprogram BOS) 

Amount Granted: 100.000€

Duration: 2011 - 2013

 

 

Research groups

 

Funding: Agencia de Gestión de Ayudas Universitarias y de Investigación (AGAUR, Generalitat de Catalunya)

Project: Grupo consolidado de investigación - Grupo Virus y Cáncer – Ayudas a grupos de Investigación SGR

Principal Investigator: Bosch FX (Coordinator)

Co-researchers: Castellsagué, X, Albero G, Alemany ME,  Bruni L, Díaz M,  Ibáñez R, Louie K, Roura E, Tous S, Klaustermeier JE, Esteban A, Florencia Y, Guimerà N, Berti L, Camon V, Clavero O, Vergara M, Company A, Guillen O, Muñoz J, Alejo M, Lloveras B, Muñoz N, Quint W, Quiros B, de Sanjosé S, Benavente Y,  Bravo IG, Brotons M, Serrano B, Puerta R, Félez M, Nicolás S, Pimenoff VN, Bedhomme S y Mengual B

Ref.: 2009 SGR 1026

Amount Granted: 70.720€

Duration: 2009-2013

 

Funding: Agencia de Gestión de Ayudas Universitarias y de Investigación (AGAUR, Generalitat de Catalunya)

Project: SGR - Grupo de investigación reconocido: EPILYMPH - Epidemiología de los linfomas.

Principal Investigator: de Sanjosé S (Coordinator)

Co-researchers: Benavente Y, Domingo E, Alarcón F, Espinosa A, Enjuanes A, Campo E, Pujana MA, Estivill X, Robles C, Costas L, Fernández de Sevilla, González Barca, Casabonne D, Godínez JM, Rodriguez V y Mena M

Ref.: 2009 SGR 1465

Amount Granted: 42.640€

Duration: 2009-2013

 

Funding: Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III)

Project: Redes Temáticas de Investigación Cooperativa en Salud. RTICCC

Principal Investigator: Bosch FX 

Co-researchers: Díaz M, Pareja L, Ribes J, Bravo IG, Gumà J, Clavero OE, Ibáñez R, Bruni L,  Sanz FX, Clèries R, Lloveras B, Company A, Muñoz J; Marcos Gragera R, Godínez JM, Camón V, Esteban A, Florencia Y, Tous S, Vergara M, Quirós B, Brotons M i Mena M

Ref.:    RD12/0036/0056

Amount Granted:  81.592,50€ by project year (renewable annually, 4 years)

Duration: 2013-2016

 

Funding: Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III)

Project: Redes Temáticas de Investigación Cooperativa en Salud. RTICCC Epidemiología

Principal Investigator: Bosch FX (Group Coordinator)

Ref.:    RD06/0020/0095

Amount Granted: 739.077,30€

Duration: 2006-2013

 

Funding: Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III)

Project: CIBER en Epidemiología y Salud Pública. Grupo 36

Principal Investigator: de Sanjosé S (Coordinator)

Ref.: CIBERESP

Amount Granted: 534.049,89 € (to the present)

Duration: Inicio 2007 – renewable annually

imatge personal
 

Group leader

Silvia de Sanjosé
Telephone  
+34 932607812
E-mail  
sdesanjose@idibell.cat
 
© 2017 Institut d'Investigació Biomèdica de Bellvitge



Results by pageInitial date
Select date
TitleFinal date
Select date
Search


Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept



Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept


Cancell

Passwords doesn’t match
The password must have at least 6 characters
The new password can not contain special characters
User register

Name
Surname
Second Surname
E-mail
User
Password
Language


Accept


Cancell




Encara no heu contestat l'enquesta de satisfacció sobre la píndola formativa sobre patents. No trigareu més de cinc minuts a fer-ho. La vostra opinió és molt important per millorar l’IDIBELL.

Voleu fer l’enquesta ara?

Yes

No




Further personal and contact information is needed to maintain IDIBELL databases.

Do you wish to fill the form now?

Yes

No





Please, remember to introduce your holiday’s planning in the application

Accept

Cancell